Development Level

Tbio 32 | 11,445
Tchem 10 | 1,598
Tclin 1 | 613
Tdark 1 | 6,588

IMPC Phenotype

abnormal embryo size 3 | 220
decreased vertical activity 3 | 208
embryonic lethality prior to t... 3 | 278
abnormal bone structure 2 | 187
abnormal eye morphology 2 | 68
abnormal placenta size 2 | 20
embryonic growth retardation 2 | 106
embryonic lethality prior to o... 2 | 239
pale yolk sac 2 | 25
preweaning lethality, incomple... 2 | 499
abnormal behavior 1 | 298
abnormal bone mineralization 1 | 38
abnormal digit morphology 1 | 10
abnormal forebrain development 1 | 20
abnormal head morphology 1 | 10
abnormal heart morphology 1 | 162
abnormal neural tube closure 1 | 46
abnormal retina morphology 1 | 71
abnormal social-conspecific in... 1 | 3
abnormal startle reflex 1 | 15
abnormal tooth morphology 1 | 24
decreased body length 1 | 101
decreased bone mineral content 1 | 151
decreased circulating choleste... 1 | 93
decreased circulating creatine... 1 | 4
decreased circulating glucose ... 1 | 126
decreased fasted circulating g... 1 | 65
decreased lean body mass 1 | 135
decreased total body fat amoun... 1 | 207
enlarged heart 1 | 210
enlarged uterus 1 | 11
hydrometra 1 | 53
hyperactivity 1 | 148
impaired glucose tolerance 1 | 75
improved glucose tolerance 1 | 79
increased bone mineral content 1 | 108
increased bone mineral density 1 | 72
increased circulating alkaline... 1 | 122
increased circulating choleste... 1 | 66
increased circulating creatine... 1 | 5
increased circulating glycerol... 1 | 9
increased circulating triglyce... 1 | 42
increased grip strength 1 | 41
increased lean body mass 1 | 172
increased monocyte cell number 1 | 63
increased startle reflex 1 | 112
increased total body fat amoun... 1 | 134
mammalian phenotype 1 | 17
pale liver 1 | 6
pallor 1 | 34
persistence of hyaloid vascula... 1 | 33
preweaning lethality, complete... 1 | 979
prolonged PR interval 1 | 15
small superior vagus ganglion 1 | 74
thrombocytopenia 1 | 56

Disease

ovarian cancer 34 | 8,520
Carcinoma 33 | 11,493
osteosarcoma 27 | 7,950
glioblastoma 20 | 5,792
medulloblastoma, large-cell 20 | 6,241
Breast cancer 19 | 3,578
atypical teratoid / rhabdoid tumor 19 | 5,112
psoriasis 19 | 6,694
Cancer 18 | 2,499
lung cancer 18 | 4,740
malignant mesothelioma 16 | 3,232
intraductal papillary-mucinous neoplasm (IPMN) 13 | 3,291
primitive neuroectodermal tumor 13 | 3,035
Endometriosis 11 | 540
Kidney cancer 11 | 2,613
astrocytic glioma 11 | 2,597
ependymoma 11 | 4,679
Breast Neoplasms 10 | 445
Mammary Neoplasms 10 | 425
intraductal papillary-mucinous adenoma (IPMA) 10 | 2,955
invasive ductal carcinoma 10 | 2,951
Rheumatoid arthritis 9 | 1,191
astrocytoma 9 | 1,146
group 3 medulloblastoma 9 | 4,104
non-small cell lung cancer 9 | 2,890
oligodendroglioma 9 | 2,850
Prostate cancer 8 | 175
adult high grade glioma 8 | 3,801
dermatomyositis 8 | 966
intraductal papillary-mucinous carcinoma (IPMC) 8 | 2,989
Intellectual disability 7 | 1,016
Multiple myeloma 7 | 1,332
Pick disease 7 | 1,894
Prostatic Neoplasms 7 | 495
Schizophrenia 7 | 1,160
acute quadriplegic myopathy 7 | 1,158
adrenocortical carcinoma 7 | 1,428
breast carcinoma 7 | 1,638
group 4 medulloblastoma 7 | 1,855
lung adenocarcinoma 7 | 2,716
pancreatic ductal adenocarcinoma liver metastasis 7 | 1,962
pituitary cancer 7 | 1,972
Carcinoma, Hepatocellular 6 | 228
Dull intelligence 6 | 645
Liver cancer 6 | 604
Liver carcinoma 6 | 240
Low intelligence 6 | 645
Mental Retardation 6 | 645
Mental deficiency 6 | 645
Muscle hypotonia 6 | 571
Poor school performance 6 | 645
Waldenstrons macroglobulinemia 6 | 765
colon cancer 6 | 1,478
Astrocytoma, Pilocytic 5 | 3,081
Cognitive delay 5 | 608
Global developmental delay 5 | 608
Mental and motor retardation 5 | 608
active Crohn's disease 5 | 922
cystic fibrosis 5 | 1,696
diabetes mellitus 5 | 1,728
ductal carcinoma in situ 5 | 1,745
juvenile dermatomyositis 5 | 1,187
nasopharyngeal carcinoma 5 | 1,058
pancreatic cancer 5 | 2,398
Broad flat nasal bridge 4 | 236
Crohn's disease 4 | 321
Cryptorchidism 4 | 296
Depressive disorder 4 | 409
Endometrial cancer 4 | 311
Epilepsy 4 | 792
Lymphoid leukemia 4 | 160
Mammary Neoplasms, Experimental 4 | 154
Nasal bridge wide 4 | 236
Obesity 4 | 678
Osteoarthritis 4 | 184
Pancreatic Neoplasm 4 | 85
Pancreatic Neoplasms 4 | 85
Seizures 4 | 596
Small head 4 | 374
Strabismus 4 | 270
hepatocellular carcinoma 4 | 547
medulloblastoma 4 | 720
non primary Sjogren syndrome sicca 4 | 891
spina bifida 4 | 1,074
subependymal giant cell astrocytoma 4 | 2,287
tuberculosis 4 | 2,010
ulcerative colitis 4 | 1,819
Acquired scoliosis 3 | 281
Atopic dermatitis 3 | 952
Curvature of spine 3 | 282
Immune system cancer 3 | 140
Leukemia 3 | 104
Mental Depression 3 | 333
aldosterone-producing adenoma 3 | 665
cutaneous lupus erythematosus 3 | 1,057
gastric cancer 3 | 459
gastric carcinoma 3 | 807
interstitial cystitis 3 | 2,312
lung carcinoma 3 | 2,843
pediatric high grade glioma 3 | 1,064

Tissue

Digestive Tract 43 | 17,369
Endocrine System 43 | 18,159
Female tissues 43 | 17,400
Male tissues 43 | 17,142
Skin and soft tissues 43 | 17,230
Urinary Tract 43 | 16,678
Blood and immune system 42 | 16,909
Liver and Pancreas 42 | 16,750
Nervous System 42 | 16,725
Respiratory system 42 | 16,393
Cardiovascular System 41 | 15,192

Target Family

Enzyme 17 | 4,145
Non-IDG 17 | 12,091
Epigenetic 4 | 242
Transcription Factor 4 | 1,400
Kinase 1 | 634
Nuclear Receptor 1 | 48

GO Process

androgen receptor signaling pa... 44 | 44
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Probable ATP-dependent RNA helicase DDX5 DDX5 Tbio Enzyme -2.08566 121.1 344
Lysine-specific demethylase 3A KDM3A Tchem Epigenetic -1.83544 74.7 253
Glutamate receptor-interacting protein 1 GRIP1 Tbio Non-IDG -2.18570 152.7 157
Homeobox protein Nkx-3.1 NKX3-1 Tbio Transcription Factor -2.13442 140.5 524
Mediator of RNA polymerase II transcription subunit 16 MED16 Tbio Enzyme -0.82499 7.04 154
Thyroid hormone receptor-associated protein 3 THRAP3 Tbio Non-IDG -0.87769 8.81 136
Mediator of RNA polymerase II transcription subunit 13 MED13 Tbio Enzyme -1.52250 26.0 53
Cystatin-11 CST11 Tbio Non-IDG -1.04700 10.5 46
Nuclear receptor-interacting protein 1 NRIP1 Tbio Non-IDG -2.21323 183.8 155
Transforming growth factor beta-1-induced transcript 1 protein TGFB1I1 Tbio Non-IDG -1.82580 89.7 147